Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: Directive 2011/89/EU | Statement: [Directive 2009/138/EC, amendedBy, Directive 2011/89/EU]

Target entity: Directive 2011/89/EU
Context triple: [Directive 2009/138/EC, amendedBy, Directive 2011/89/EU]

• A. Directive 2010/53/EU
  Directive 2010/53/EU is a European Union law that sets common standards for the quality and safety of human organs intended for transplantation across EU member states.
• B. Directive 2012/26/EU
  Directive 2012/26/EU is a European Union legislative act that strengthened pharmacovigilance rules and safety monitoring for medicinal products for human use by updating the EU’s medicines regulatory framework.
• C. Directive 2014/51/EU
  Directive 2014/51/EU is a European Union legislative act that updated and aligned financial services legislation, particularly in insurance and banking, to strengthen regulatory frameworks and supervision in the wake of the financial crisis.
• D. Directive 2010/84/EU
  Directive 2010/84/EU is a European Union legislative act that significantly strengthened and modernized the EU pharmacovigilance system to improve the monitoring and safety of medicinal products for human use.
• E. Directive 2013/37/EU
  Directive 2013/37/EU is a European Union law that updated and expanded the rules on the re-use of public sector information to promote transparency, innovation, and economic activity across the EU.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Target entity: Directive 2011/89/EU
Target entity description: Directive 2011/89/EU is an EU legislative act that strengthened and harmonized the supervision of financial conglomerates, particularly in the insurance and banking sectors, to enhance financial stability and regulatory oversight.

• A. Directive 2010/53/EU
  Directive 2010/53/EU is a European Union law that sets common standards for the quality and safety of human organs intended for transplantation across EU member states.
• B. Directive 2012/26/EU
  Directive 2012/26/EU is a European Union legislative act that strengthened pharmacovigilance rules and safety monitoring for medicinal products for human use by updating the EU’s medicines regulatory framework.
• C. Directive 2014/51/EU
  Directive 2014/51/EU is a European Union legislative act that updated and aligned financial services legislation, particularly in insurance and banking, to strengthen regulatory frameworks and supervision in the wake of the financial crisis.
• D. Directive 2010/84/EU
  Directive 2010/84/EU is a European Union legislative act that significantly strengthened and modernized the EU pharmacovigilance system to improve the monitoring and safety of medicinal products for human use.
• E. Directive 2013/37/EU
  Directive 2013/37/EU is a European Union law that updated and expanded the rules on the re-use of public sector information to promote transparency, innovation, and economic activity across the EU.
• F. None of above. chosen